Navigation Links
Vein Condition May Mask Serious Clot Disorder
Date:7/20/2009

Superficial vein thrombosis linked to deep vein thrombosis, study says

MONDAY, July 20 (HealthDay News) -- A supposedly harmless condition -- superficial vein thrombosis, or varicose veins that have become swollen and painful -- may herald the presence of a more dangerous problem.

One-quarter of patients with superficial vein thrombosis (SVT) in an Austrian study actually had deep vein thrombosis (DVT), a potentially life-threatening condition.

"The diagnosis of [SVT] has long been considered to be a benign entity which could be managed in the doctor's office [but] in fact may be the tip of the iceberg," said Dr. Robert Lookstein, an associate professor of radiology and surgery at the Mount Sinai School of Medicine in New York City.

"I think it's a good idea for anybody with [superficial vein thrombosis] to undergo routine ultrasound screening of the deep veins of their legs to exclude this very, very serious diagnosis," Lookstein continued.

This advice does not apply to individuals with "regular" varicose veins, only to those who are experiencing varicose veins that are "quite engorged and firm to the touch," Lookstein said.

Many doctors may already be on the alert.

"This [finding] does not surprise me," said Dr. Robert Rosen, director of vascular intervention at Lenox Hill Hospital in New York City. "They [the study authors] are documenting something that doctors are already doing."

SVT, explained Lookstein, happens when varicose veins in the calves or thighs become filled with blood clots. "They become painful, can become hot and patients can have low-grade fevers," he said. "It's a condition that can be quite uncomfortable."

Unlike SVT, which is visible on the surface of the skin, DVT is a blood clot that forms in veins deeper in the body. Complications can include pulmonary embolism, when a piece of the clot in the leg breaks off and travels to the lung; and post-thrombotic syndrome, in which the clots in the leg never heal, sometimes leading to loss of function of the legs, Lookstein said.

"This can transform somebody who would otherwise be a working member of the community and turn them into somebody unable to work, somebody who is bedbound," he said.

The authors of the new study, from the Medical University of Graz in Austria, looked at 46 patients (32 women and 14 men) who came to the dermatology department with SVT.

One-quarter of the patients had DVT, usually without symptoms. Of these, three-quarters had DVT in the same leg as the superficial vein thrombosis, 9 percent had DVT in the other leg and 18 percent had it in both legs, the researchers said.

Anybody with SVT should undergo routine screening with duplex ultrasound, which can be performed either in a doctor's office or by a vascular specialist, Lookstein said.

The findings were published in the July issue of the Archives of Dermatology.

More information

The U.S. National Heart, Lung, and Blood Institute has more on deep vein thrombosis.



SOURCES: Robert Rosen, M.D., director, vascular intervention, Lenox Hill Hospital, New York City; Robert Lookstein, M.D., associate professor, radiology and surgery, Mount Sinai School of Medicine, New York City; July 2009 Archives of Dermatology


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Worlds First Deep Brain Stimulation Device Approved for Treatment of Psychiatric Condition in Europe
2. Health clinic conditions may be to blame for decrease in primary care physicians
3. Aging Institute May Die Before its Time, Due To Economic Conditions Yet Washington Based Non-Profit Organization Forges Ahead with Scheduled Landmark Conference
4. Helen Sher Launches Her Rosacea Awareness Campaign 2009 to Help Sufferers of this Distressing Condition
5. Kids With Eye Condition at Risk for Poor Mental Health
6. 63 percent of RA patients suffer psychiatric disorders, with depressive spectrum conditions most likely
7. Omega-3 EPA: Treatment for a Heart Condition
8. XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration
9. Obesity and diabetes double risk of HF -- patients with both conditions very difficult to treat
10. Common migraine pain condition also prevalent in cluster headache
11. Increasingly Competitive European Dental Implant Market to Reach Over $2.7 Billion by 2013 Despite Unfavorable Economic Conditions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... ... 2016 , ... A revolution is underway. Brooklyn-based company, ... for the millions of people who require these medical transport services annually. ... the use of technology. Now, SmartEMS has put forth an industry-changing app that ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: